Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
search
Join
FREE
This site is intended for healthcare professionals
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
Join
FREE
Edition
European
US
Rheumatology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
Diabetes Drug Metformin Shows Potential in Osteoarthritis Care
January 2026
Evidence from a clinical trial and long-term cohort studies suggests metformin, widely used in diabetes, may reduce knee osteoarthritis pain and lower future osteoarthritis risk.
Read more
31 Jul 2020
Novel Opioid Provides Less Addictive Pain Relief and May Slow Osteoarthritis Progression
ADDICTIVE opioids are routinely taken by many people with arthritis to manage their pain. Kappa opioid receptor (KOR) agonists are known to be less…
31 Jul 2020
Is Tocilizumab Beneficial to Critically Ill COVID-19 Patients?
Tocilizumab, an immunosuppressant originally developed as a rheumatoid arthritis treatment, has demonstrated further benefits in treating patients…
5 May 2020
Initial Results of the COVID-19 Global Rheumatology Alliance Provider Registry
COVID-19, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is of particular concern to patients who are immunocompromised…
5 May 2020
New Evidence Linking Gout and Risk of Heart Failure
GOUT has been linked to increased risk of incident heart failure in older adults according to a recent study by Dr Lisandro Colantonio and colleagues…
5 May 2020
Imaging Data Poses the Question: Is COVID-19 More Than a Lung Infection?
RAISED blood levels of D-dimer have been strongly associated with poor prognosis of coronavirus causing experts to investigate and provide guidance…
2 Apr 2020
Rheumatoid Arthritis Drug to be Repurposed for COVID-19 Therapy in Phase II/III Clinical Trial
The U.S. Department of Human Health and Services’ (HHS) Office of the Assistant Secretary for Preparedness and Response (ASPR)…
11 Feb 2020
Prevention of Fracture Risk with Supplementation Combination
DAILY supplementation with vitamin D and calcium showed great potential for reducing risk of fracture in a recent study…
11 Feb 2020
IL-4 and IL-13 Prevent Migration of Neutrophils to Inflammation Site
NOVEL drugs for the treatment of rheumatoid arthritis could earn a place in the medicine cabinet following the results of a study…
Loading posts...
« Previous
1
…
27
28
29
30
31
…
39
Next »
We’ve noticed you’re accessing
from
North/South America.
View
View